Chemoradiation remains best treatment for locally advanced cervical cancer

Prof Gupta talks with ecancer at the ESMO 2017 Congress about a randomised controlled trial looking at neoadjuvant chemotherapy followed by surgery versus concurrent cisplatin and radiation therapy in patients with stage IB2 to IIB squamous carcinoma of cervix.

He goes on to discuss the results of the trial and explains that chemoradiation remains the best choice treatment for locally advanced cervical cancer.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

More from ESMO 2017 : http://ecancer.org/conference/722-esmo-2017.php

Ecancer website: http://ecancer.org/video/index.php
Twitter: @ecancer
Facebook: https://www.facebook.com/ecancer